Literature DB >> 7199989

Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics.

J H Henriksen, N J Christensen, H Ring-Larsen.   

Abstract

Plasma noradrenaline (NA) and adrenaline (A) concentrations were related to various haemodynamic parameters in fifteen patients with cirrhosis. In supine position at rest plasma NA and A in peripheral venous blood were significantly higher in patients with cirrhosis than in normal subjects. Mean plasma NA averaged 0.66 and 0.21 ng/ml, respectively (P less than 0.01). The corresponding values for plasma A were 0.14 and 0.05 ng/ml (P less than 0.03). Splanchnic arterial-hepatic venous extraction ratio of NA in patients with cirrhosis averaged 0.46 (P less than 0.01). The right kidney released NA into the systemic circulation. Renal venous plasma NA exceeded arterial concentration by 38% (P less than 0.02). NA concentrations in femoral vein and ascitic fluid were not different from that of arterial plasma. Plasma NA was positively correlated to wedged hepatic vein pressure (r = 0.86, P less than 0.001) and to heart rate (r = 0.61, P less than 0.02), but inversely correlated to plasma volume (r = 0.83, P less than 0.01) in cirrhotic patients. Arterial blood pressure was reduced in these patients compared to controls (P less than 0.02), but not significantly correlated to plasma NA. The increased plasma NA indicates that sympathetic nervous activity is enhanced in patients with cirrhosis. Based on the above positive correlation between NA and heart rate and the significant release of NA from the kidney, it may be hypothesized that the increased sympathetic nervous activity especially involves heart and kidney. This response may be mediated by baro- and volume receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7199989     DOI: 10.1111/j.1475-097x.1981.tb00898.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  16 in total

Review 1.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

2.  Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis.

Authors:  A J MacGilchrist; N M Deighton; C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

3.  Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.

Authors:  H Ring-Larsen; J H Henriksen; C Wilken; J Clausen; H Pals; N J Christensen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

4.  Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis.

Authors:  A Braillon; P Cales; D Valla; D Gaudy; P Geoffroy; D Lebrec
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

5.  Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites. Evaluation by univariate and multivariate analyses.

Authors:  S Gentile; M Angelico; M G Chiappini; G Peruzzi; S Vulterini
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

6.  Reduced portosystemic hemodynamic responsiveness after orthostasis in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Ikegami; M Sumino; K Oho; M Sakaki; H Shigemori; K Tanikawa; J Iwao
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

7.  Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.

Authors:  J H Henriksen; H Ring-Larsen; I L Kanstrup; N J Christensen
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

8.  [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].

Authors:  R Brunkhorst; E Wrenger; K Kühn; F W Schmidt; K Koch
Journal:  Klin Wochenschr       Date:  1989-08-01

9.  Effect of captopril on renin and blood pressure in cirrhosis.

Authors:  B Stanek; F Renner; A Sedlmayer; K Silberbauer
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Tyrosine loading in patients with hepatic cirrhosis: lack of effect on plasma catecholamines.

Authors:  H Wernze; K L Diehl; P Hermann; G Peter
Journal:  Klin Wochenschr       Date:  1986-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.